1. Home
  2. TBBK vs SLNO Comparison

TBBK vs SLNO Comparison

Compare TBBK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

HOLD

Current Price

$52.75

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$52.97

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBBK
SLNO
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
TBBK
SLNO
Price
$52.75
$52.97
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$69.00
$83.00
AVG Volume (30 Days)
382.4K
2.0M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
14.69
108.90
EPS
1.41
0.59
Revenue
$141,147,000.00
$1,450,788.00
Revenue This Year
N/A
$150.46
Revenue Next Year
$8.16
$50.37
P/E Ratio
$38.07
$89.71
Revenue Growth
20.85
138.82
52 Week Low
$48.86
$29.43
52 Week High
$81.65
$89.12

Technical Indicators

Market Signals
Indicator
TBBK
SLNO
Relative Strength Index (RSI) 32.38 77.12
Support Level $50.85 $48.91
Resistance Level $55.74 $55.47
Average True Range (ATR) 1.99 0.07
MACD -0.93 -0.55
Stochastic Oscillator 5.07 92.73

Price Performance

Historical Comparison
TBBK
SLNO

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: